An investigation of extended-interval dosing of atezolizumab in Japanese patients with advanced solid tumors: safety and pharmacokinetics of a dose of 1680 mg every 4 weeks
Sign Up to like & getrecommendations! Published in 2025 at "Investigational New Drugs"
DOI: 10.1007/s10637-024-01498-0
Abstract: In Japan, atezolizumab is indicated for several cancers at a dose of 1200 mg every 3 weeks or 840 mg every 2 weeks. This open-label study (jRCT2031220151) aimed to assess an atezolizumab monotherapy dose of… read more here.
Keywords: every weeks; 1680 every; japanese patients; solid tumors ... See more keywords